The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
Open accessAbstract
A major cause of the paucity of new starting points for drug discovery is the lack of interaction between academia and industry. Much of the global resource in biology is present in universities, whereas the focus of medicinal chemistry is still largely within industry. Open source drug discovery, with sharing of information, is clearly a first step towards overcoming this gap. But the interface could especially be bridged through a scale-up of open sharing of physical compounds, which would accelerate the finding of new starting points for drug discovery. The Medicines for Malaria Venture Malaria Box is a collection of over 400 compounds representing families of structures identified in phenotypic screens of pharmaceutical and academic libraries against the Plasmodium falciparum malaria parasite. The set has now been distributed to almost 200 research groups globally in the last two years, with the only stipulation that information from the screens is deposited in the public domain. This paper reports for the first time on 236 screens that have been carried out against the Malaria Box and compares these results with 55 assays that were previously published, in a format that allows a meta-analysis of the combined dataset. The combined biochemical and cellular assays presented here suggest mechanisms of action for 135 (34%) of the compounds active in killing multiple life-cycle stages of the malaria parasite, including asexual blood, liver, gametocyte, gametes and insect ookinete stages. In addition, many compounds demonstrated activity against other pathogens, showing hits in assays with 16 protozoa, 7 helminths, 9 bacterial and mycobacterial species, the dengue fever mosquito vector, and the NCI60 human cancer cell line panel of 60 human tumor cell lines. Toxicological, pharmacokinetic and metabolic properties were collected on all the compounds, assisting in the selection of the most promising candidates for murine proof-of-concept experiments and medicinal chemistry programs. The data for all of these assays are presented and analyzed to show how outstanding leads for many indications can be selected. These results reveal the immense potential for translating the dispersed expertise in biological assays involving human pathogens into drug discovery starting points, by providing open access to new families of molecules, and emphasize how a small additional investment made to help acquire and distribute compounds, and sharing the data, can catalyze drug discovery for dozens of different indications. Another lesson is that when multiple screens from different groups are run on the same library, results can be integrated quickly to select the most valuable starting points for subsequent medicinal chemistry efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
Self-citationSpiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Self-citationThousands of chemical starting points for antimalarial lead identification
Gamo, F.-J., Sanz, L. M., Vidal, J., de Cozar, C., Alvarez, E., Lavandera, J.-L., Vanderwall, D. E., Green, D. V. S., Kumar, V., Hasan, S., et al. (2010) · Nature · doi:10.1038/nature09107 · Cited by 996
Self-citationHit and lead criteria in drug discovery for infectious diseases of the developing world
Katsuno, K., Burrows, J. N., Duncan, K., van Huijsduijnen, R. H., Kaneko, T., Kita, K., Mowbray, C. E., Schmatz, D., Warner, P., & Slingsby, B. T. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4683 · Cited by 607
Self-citationChemical genetics of Plasmodium falciparum
Guiguemde, W. A., Shelat, A. A., Bouck, D., Duffy, S., Crowther, G. J., Davis, P. H., Smithson, D. C., Connelly, M., Clark, J., Zhu, F., et al. (2010) · Nature · doi:10.1038/nature09099 · Cited by 566
Self-citationSpecific role of mitochondrial electron transport in blood-stage Plasmodium falciparum
Painter, H. J., Morrisey, J. M., Mather, M. W., & Vaidya, A. B. (2007) · Nature · doi:10.1038/nature05572 · Cited by 512
Drugs and Valvular Heart Disease
Roth, B. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068265 · Cited by 479 · cited 1×
“One of the most severe GPCR-related adverse effects is cardiac valvulopathy linked to 5-HT2B activation [11, 12].”
Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine
Fitzgerald, L. W., Burn, T. C., Brown, B. S., Patterson, J. P., Corjay, M. H., Valentine, P. A., Sun, J.-H., Link, J. R., Abbaszade, I., Hollis, J. M., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26444-0 · Cited by 440
Whitebread, S., Hamon, J., Bojanic, D., & Urban, L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03632-9 · Cited by 404
Phillips, M. A., Lotharius, J., Marsh, K., White, J., Dayan, A., White, K. L., Njoroge, J. W., El Mazouni, F., Lao, Y., Kokkonda, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa6645 · Cited by 371
Self-citationThe Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
Spangenberg, T., Burrows, J. N., Kowalczyk, P., McDonald, S., Wells, T. N. C., & Willis, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062906 · Cited by 341
Self-citationImaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M. C., Wu, T., Barnes, S. W., Bopp, S. E., Borboa, R., Bright, A. T., Che, J., et al. (2011) · Science · doi:10.1126/science.1211936 · Cited by 338
Self-citationKirk, K., Horner, H. A., Elford, B. C., Ellory, J. C., & Newbold, C. I. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41868-0 · Cited by 268
Self-citationSpillman, N. J., Allen, R. J. W., McNamara, C. W., Yeung, B. K. S., Winzeler, E. A., Diagana, T. T., & Kirk, K. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2012.12.006 · Cited by 246
Self-citationJiménez-Díaz, M. B., Ebert, D., Salinas, Y., Pradhan, A., Lehane, A. M., Myrand-Lapierre, M.-E., O’Loughlin, K. G., Shackleford, D. M., Justino de Almeida, M., Carrillo, A. K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414221111 · Cited by 245
Self-citationPlasmodium Dihydroorotate Dehydrogenase: A Promising Target for Novel Anti-Malarial Chemotherapy
A. Phillips, M., & K. Rathod, P. (2010) · Infectious Disorders - Drug Targets · doi:10.2174/187152610791163336 · Cited by 229
Ginsburg, H., Kutner, S., Krugliak, M., & Ioav Cabantchik, Z. (1985) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(85)90059-3 · Cited by 216
Chan, T. S., Yu, H., Moore, A., Khetani, S. R., & Tweedie, D. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053397 · Cited by 160
Identification of inhibitors of Plasmodium falciparum gametocyte development
Duffy, S., & Avery, V. M. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-408 · Cited by 158
Self-citationRole of hERG potassium channel assays in drug development
Priest, B. T., Bell, I. M., & García, M. I. (2008) · Channels · doi:10.4161/chan.2.2.6004 · Cited by 151
Taylor, M. J., Hoerauf, A. M., Townson, S., Slatko, B. E., & Ward, S. A. (2013) · Parasitology · doi:10.1017/s0031182013001108 · Cited by 143
Self-citationPerturbation of the pump-leak balance for Na+ and K+ in malaria-infected erythrocytes
Staines, H. M., Ellory, J. C., & Kirk, K. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1576 · Cited by 140
Self-citationvan Pelt-Koops, J. C., Pett, H., Graumans, W., van der Vegte-Bolmer, M., van Gemert, G. J., Rottmann, M., Yeung, B. K. S., Diagana, T. T., & Sauerwein, R. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06377-11 · Cited by 138
Vaidya, A. B., Morrisey, J. M., Zhang, Z., Das, S., Daly, T. M., Otto, T. D., Spillman, N. J., Wyvratt, M. J., Siegl, P. K. S., Marfurt, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6521 · Cited by 136
Self-citationLucantoni, L., Duffy, S., Adjalley, S. H., Fidock, D. A., & Avery, V. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00870-13 · Cited by 112
Self-citationReader, J., van der Watt, M., Theron, A., Lauterbach, S. B., Rossouw, C., Engelbrecht, D., Wepener, M., Smit, A., Leroy, D., Mancama, D. T., et al. (2015) · Malaria Journal · doi:10.1186/s12936-015-0718-z · Cited by 112
Self-citationFlannery, E. L., McNamara, C. W., Kim, S. W., Sakata, T., Li, F., Teng, C. H., Gagaring, K., Manary, M. J., Barboa, R., Meister, S., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500616x · Cited by 104
Self-citationDiverse chemotypes disrupt ion homeostasis in the malaria parasite
Lehane, A. M., Ridgway, M. C., Baker, E., & Kirk, K. (2014) · Molecular Microbiology · doi:10.1111/mmi.12765 · Cited by 93
Self-citationWu, W. C. H., Herrera, Z., Ebert, D., Baska, K., Cho, S. H., DeRisi, J. L., & Yeh, E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03342-14 · Cited by 84
Self-citationBessoff, K. E., Spangenberg, T., Foderaro, J. E., Jumani, R. S., Ward, G. E., & Huston, C. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02641-13 · Cited by 83
Self-citationKnocking out multigene redundancies via cycles of sexual assortment and fluorescence selection
Suzuki, Y., Onge, R. P. S., Mani, R., King, O. D., Heilbut, A., Labunskyy, V. M., Chen, W., Pham, L., Zhang, L. V., Tong, A. H. Y., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1550 · Cited by 78
Rizk, M. A., El‒Sayed, S. A. E., Terkawi, M. A., Youssef, M. A., Said, E. S. E. S. E., El‐Sayed, G., El‐Khodery, S., El-Ashker, M. R., Elsify, A. M., Omar, M. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125276 · Cited by 78
Self-citationInhibitory effect of allicin on the growth of Babesia and Theileria equi parasites
Salama, A. A., AbouLaila, M. R., Terkawi, M. A., Mousa, A., Elsify, A. M., Allaam, M. A., Zaghawa, A. A., Yokoyama, N., & Igarashi, I. (2013) · Parasitology Research · doi:10.1007/s00436-013-3654-2 · Cited by 74
Self-citationBoyom, F. F., Fokou, P. V. T., Tchokouaha, L. R. Y., Spangenberg, T., Mfopa, A. N., Toghueo, R. M. K., Mbouna, C. D. J., Donfack, V. F. D., & Zollo, P. H. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02541-14 · Cited by 74
Self-citationSpiroindolone Nitd609 is a Novel Antimalarial Drug that Targets the P-type Atpase PfATP4
Turner, H. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.177 · Cited by 68
Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum
Avery, V. M., Bashyam, S., Burrows, J. N., Duffy, S., Papadatos, G., Puthukkuti, S., Sambandan, Y., Singh, S. V., Spangenberg, T., Waterson, D., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-190 · Cited by 62
Self-citationLinares, M., Viera, S., Crespo, B., Franco, V., Gómez-Lorenzo, M. G., Jiménez-Dı́az, M. B., Angulo‐Barturen, Í., Sanz, L. M., & Gamo, F. (2015) · Malaria Journal · doi:10.1186/s12936-015-0962-2 · Cited by 59
Self-citationLucantoni, L., Silvestrini, F., Signore, M., Siciliano, G., Eldering, M., Dechering, K. J., Avery, V. M., & Alano, P. (2015) · Scientific Reports · doi:10.1038/srep16414 · Cited by 59
Self-citationLundström‐Stadelmann, B., Rufener, R., Aeschbacher, D., Spiliotis, M., Gottstein, B., & Hemphill, A. F. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004535 · Cited by 59
Self-citationImlay, L. S., Armstrong, C. M., Masters, M. C., Li, T., Price, K. E., Edwards, R. L., Mann, K. M., Li, L. X., Stallings, C. L., Berry, N. G., et al. (2015) · ACS Infectious Diseases · doi:10.1021/id500047s · Cited by 57
Sanders, N. G., Sullivan, D. J., Mlambo, G., Dimopoulos, G., & Tripathi, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105817 · Cited by 56
Self-citationCrowther, G. J., Hillesland, H. K., Keyloun, K. R., Reid, M. C., Lafuente-Monasterio, M. J., Ghidelli, S., Leonard, S. E., He, P., Jones, J. C., Krahn, M. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149996 · Cited by 56
Self-citationHain, A. U. P., Bartee, D., Sanders, N. G., Miller, A. S., Sullivan, D. J., Levitskaya, J., Meyers, C. L. F., & Bosch, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401675a · Cited by 49
Self-citationPrediction of the P. falciparum Target Space Relevant to Malaria Drug Discovery
Spitzmüller, A., & Mestres, J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003257 · Cited by 41
Self-citationFletcher, S., & Avery, V. M. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-343 · Cited by 39
Self-citationSalama, A. A., AbouLaila, M. R., MOUSSA, A. A. E. M., Nayel, M. A., Elsify, A. M., Terkawi, M. A., Hassan, H. Y., Yokoyama, N., & Igarashi, I. (2012) · Veterinary Parasitology · doi:10.1016/j.vetpar.2012.08.022 · Cited by 37
Self-citationIdentification of β-hematin inhibitors in the MMV Malaria Box
Fong, K. Y., Sandlin, R. D., & Wright, D. W. (2015) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2015.05.003 · Cited by 35
Frame, I. J., Deniskin, R., Rinderspacher, A., Katz, F. S., Deng, S.-X., Moir, R. D., Adjalley, S. H., Coburn‐Flynn, O., Fidock, D. A., Willis, I. M., et al. (2015) · ACS Chemical Biology · doi:10.1021/cb500981y · Cited by 34
Self-citationActivities ofN,N′-Diarylurea MMV665852 Analogs against Schistosoma mansoni
Cowan, N., Dätwyler, P., Ernst, B., Wang, C., Vennerstrom, J. L., Spangenberg, T., & Keiser, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04463-14 · Cited by 32
Self-citationÇelik, H., Hong, S.-H., Colón-López, D. D., Han, J. J., Saygıdeğer, Y., Minas, T. Z., Swift, M. R., Paige, M. A., Glasgow, E. F., Toretsky, J. A., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0511 · Cited by 23
Self-citationSmall Molecule Screen for Candidate Antimalarials Targeting Plasmodium Kinesin-5
Liu, L., Richard, J. M., Kim, S.-Y., & Wojcik, E. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551408 · Cited by 20
Self-citationEvaluation of the inhibitory effects of miltefosine on the growth of Babesia and Theileria parasites
AbouLaila, M. R., Batadoj, D., Salama, A. A., Munkhjargal, T., Ichikawa‐Seki, M., Terkawi, M. A., Yokoyama, N., & Igarashi, I. (2014) · Veterinary Parasitology · doi:10.1016/j.vetpar.2014.05.023 · Cited by 16
Self-citationTiwari, N., Reynolds, P., & Calderón, Á. I. (2016) · Molecules · doi:10.3390/molecules21040424 · Cited by 16
MMV Malaria Box Activity Screening in Dormant Plasmodium falciparum Phenotypes
Galusic, S. (2015) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Cited by
Zhang, M., Wang, C., Otto, T. D., Oberstaller, J., Liao, X., Adapa, S. R., Udenze, K., Bronner, I. F., Casandra, D., Mayho, M., et al. (2018) · Science · doi:10.1126/science.aap7847 · Cited by 922
Self-citationThe past, present and future of anti-malarial medicines
Tse, E. G., Korsik, M., & Todd, M. H. (2019) · Malaria Journal · doi:10.1186/s12936-019-2724-z · Cited by 471
Edwards, J., Wilmott, J. S., Madore, J., Gide, T. N., Quek, C., Tasker, A., Ferguson, A., Chen, J., Hewavisenti, R., Hersey, P., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2257 · Cited by 431
The viral protein corona directs viral pathogenesis and amyloid aggregation
Ezzat, K., Pernemalm, M., Pålsson, S., Roberts, T. C., Järver, P., Dondalska, A., Bestas, B., Sobkowiak, M. J., Levänen, B., Sköld, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10192-2 · Cited by 209
Fungal persister cells: The basis for recalcitrant infections?
Wuyts, J., Van Dijck, P., & Holtappels, M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007301 · Cited by 136
Metadata
- Authors
- Van Voorhis, W. C., Adams, J. H., Adelfio, R., Ahyong, V., Akabas, M. H., Alano, P., Alday, A., Alemán Resto, Y., Alsibaee, A., Alzualde, A., Andrews, K. T., Avery, S. V., Avery, V. M., Ayong, L., Baker, M., Baker, S., Ben Mamoun, C., Bhatia, S., Bickle, Q., Bounaadja, L., Bowling, T., Bosch, J., Boucher, L. E., Boyom, F. F., Brea, J., Brennan, M., Burton, A., Caffrey, C. R., Camarda, G., Carrasquilla, M., Carter, D., Belen Cassera, M., Chih-Chien Cheng, K., Chindaudomsate, W., Chubb, A., Colon, B. L., Colón-López, D. D., Corbett, Y., Crowther, G. J., Cowan, N., D’Alessandro, S., Le Dang, N., Delves, M., DeRisi, J. L., Du, A. Y., Duffy, S., Abd El-Salam El-Sayed, S., Ferdig, M. T., Fernández Robledo, J. A., Fidock, D. A., Florent, I., Fokou, P. V. T., Galstian, A., Gamo, F. J., Gokool, S., Gold, B., Golub, T., Goldgof, G. M., Guha, R., Guiguemde, W. A., Gural, N., Guy, R. K., Hansen, M. A. E., Hanson, K. K., Hemphill, A., Hooft van Huijsduijnen, R., Horii, T., Horrocks, P., Hughes, T. B., Huston, C., Igarashi, I., Ingram-Sieber, K., Itoe, M. A., Jadhav, A., Naranuntarat Jensen, A., Jensen, L. T., Jiang, R. H. Y., Kaiser, A., Keiser, J., Ketas, T., Kicka, S., Kim, S., Kirk, K., Kumar, V. P., Kyle, D. E., Lafuente, M. J., Landfear, S., Lee, N., Lee, S., Lehane, A. M., Li, F., Little, D., Liu, L., Llinás, M., Loza, M. I., Lubar, A., Lucantoni, L., Lucet, I., Maes, L., Mancama, D., Mansour, N. R., March, S., McGowan, S., Medina Vera, I., Meister, S., Mercer, L., Mestres, J., Mfopa, A. N., Misra, R. N., Moon, S., Moore, J. P., Morais Rodrigues da Costa, F., Müller, J., Muriana, A., Nakazawa Hewitt, S., Nare, B., Nathan, C., Narraidoo, N., Nawaratna, S., Ojo, K. K., Ortiz, D., Panic, G., Papadatos, G., Parapini, S., Patra, K., Pham, N., Prats, S., Plouffe, D. M., Poulsen, S.-A., Pradhan, A., Quevedo, C., Quinn, R. J., Rice, C. A., Abdo Rizk, M., Ruecker, A., St. Onge, R., Salgado Ferreira, R., Samra, J., Robinett, N. G., Schlecht, U., Schmitt, M., Silva Villela, F., Silvestrini, F., Sinden, R., Smith, D. A., Soldati, T., Spitzmüller, A., Stamm, S. M., Sullivan, D. J., Sullivan, W., Suresh, S., Suzuki, B. M., Suzuki, Y., Swamidass, S. J., Taramelli, D., Tchokouaha, L. R. Y., Theron, A., Thomas, D., Tonissen, K. F., Townson, S., Tripathi, A. K., Trofimov, V., Udenze, K. O., Ullah, I., Vallieres, C., Vigil, E., Vinetz, J. M., Voong Vinh, P., Vu, H., Watanabe, N.-A., Weatherby, K., White, P. M., Wilks, A. F., Winzeler, E. A., Wojcik, E., Wree, M., Wu, W., Yokoyama, N., Zollo, P. H. A., Abla, N., Blasco, B., Burrows, J., Laleu, B., Leroy, D., Spangenberg, T., Wells, T., & Willis, P. A.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-07-28
- Volume
- 12
- Issue
- 7
- Pages
- e1005763
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2488914148
- Cited by
- 435
- References
- 55
- FWCI
- 57.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.